4d
Zacks Investment Research on MSNBayer Licenses PRMT5 inhibitor From Suzhou Puhe BioPharmaBayer BAYRY announced a licensing agreement with Suzhou Puhe BioPharma Co., a clinical-stage biotechnology company.Suzhou Puhe BioPharma is focused on the research and development of innovative ...
The German firm licensed a PRMT5 inhibitor that’s now in Phase 1 testing. Elsewhere, GSK is testing an intriguing hypothesis ...
Bayer (BAYZF) stock in focus as the company inks a licensing deal with Puhe BioPharma to develop a cancer candidate targeting ...
Bayer said it was ordered to pay $2.1 billion in a case about its Roundup weedkiller after a jury in a Georgia state court ...
The residence belongs to an executive at Bayer, the German pharmaceutical company valued at nearly $50 billion which makes medicines such as Aleve and Aspirin. A company spokesperson confirmed ...
Welcome to Sportstar’s highlights of the Bayer Leverkusen vs Bayern Munich UEFA Champions League 2024-25 Round of 16 second leg match being played at the BayArena. Bayer Leverkusen coach Xabi Alonso ...
Bayer and Bayern will lock horns in the UEFA Champions League. This is the 2nd leg match of the Round of 16 fixture in UCL. Bayern had won the previous encounter between both sides with a 3-0 lead.
Bayern Munich finally got one over Xabi Alonso's Bayer Leverkusen in the first leg of their Champions League round of 16 tie, and they'll head to the BayArena on Tuesday with a 3-0 lead.
The Bavarian giants hold a commanding 3-0 advantage over Bayer Leverkusen heading into the second leg, leaving their opponents with a mountain to climb. Xabi Alonso has worked wonders since taking ...
Fierce rivals face off in the second leg of the UEFA Champions League Round of 16 as Bayer Leverkusen try to come back against Harry Kane and Bayern Munich on Tuesday on Paramount+. These familiar ...
Vincent Kompany's side produced a dominant display in the Round of 16 first leg which was aided by Bayer Leverkusen failing to show up for such a historic fixture. IMAGO / Jan Huebner The early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results